Show simple item record
Author | dc.contributor.author | Storpirtis, Sílvia | |
Author | dc.contributor.author | Gai, Maria Nella | |
Author | dc.contributor.author | Cristofoletti, Rodrigo | |
Admission date | dc.date.accessioned | 2018-12-20T15:04:38Z | |
Available date | dc.date.available | 2018-12-20T15:04:38Z | |
Publication date | dc.date.issued | 2014 | |
Cita de ítem | dc.identifier.citation | Pharmaceuticals Policy and Law, Volumen 16, Issue 3-4, 2018, Pages 225-248 | |
Identifier | dc.identifier.issn | 2210495X | |
Identifier | dc.identifier.issn | 13892827 | |
Identifier | dc.identifier.other | 10.3233/PPL-140386 | |
Identifier | dc.identifier.uri | https://repositorio.uchile.cl/handle/2250/157568 | |
Abstract | dc.description.abstract | © 2014 - Network of Centres for Study of Pharmaceutical Law. All rights reserved.In the XIX and XX centuries, Latin American countries have experienced several changes on politics and economics, facing problems related to progress and growth, technological development, demographic transition, and the environment. In the 2010s this region presents a high level of health demands, which causes financial difficulties, especially in expenditures with medicines. In this scenario have emerged policies to regulate and harmonize the register of generic and similar products based on in vitro and in vivo assays that support therapeutical equivalence and interchangeability, but heterogeneity is still observed, especially in terms of the assessment criteria and time from application until marketing authorization. Data obtained from the pharmaceutical market predict that this segment could reach USD 1,200 billion by 2016, mainly from market expansion in the leading emerging countries and from generi | |
Lenguage | dc.language.iso | en | |
Publisher | dc.publisher | IOS Press | |
Type of license | dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Chile | |
Link to License | dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/cl/ | |
Source | dc.source | Pharmaceuticals Policy and Law | |
Keywords | dc.subject | Bioequivalence | |
Keywords | dc.subject | Biowaivers | |
Keywords | dc.subject | Generic drugs | |
Keywords | dc.subject | Latin American countries | |
Keywords | dc.subject | Pharmaceutical regulation | |
Keywords | dc.subject | Similar products | |
Título | dc.title | Generic and similar products in Latin American countries: Current aspects and perspectives on bioequivalence and biowaivers | |
Document type | dc.type | Artículo de revista | |
Cataloguer | uchile.catalogador | SCOPUS | |
Indexation | uchile.index | Artículo de publicación SCOPUS | |
uchile.cosecha | uchile.cosecha | SI | |
Files in this item
- Name:
- item_84908401340.pdf
- Size:
- 2.061Kb
- Format:
- PDF
This item appears in the following Collection(s)
Show simple item record
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile